Ephraim Resources Limited Share Price

Stocks

EPA

AU000000EPA3

Biotechnology & Medical Research

End-of-day quote 04:47:55 28/02/2017 GMT 5-day change 1st Jan Change
0.002000 AUD +100.00% Intraday chart for Ephraim Resources Limited +100.00% -

Valuation: Ephraim Resources Limited

Market Cap 3.08M 2.64M 2.47M 2.26M 4.24M 295M 4.3M 29.17M 11.37M 148M 11.57M 11.31M 490M P/E 2017
-6.41x
P/E 2018 -3.16x
Enterprise Value 3.63M 3.11M 2.91M 2.66M 5M 347M 5.06M 34.36M 13.4M 174M 13.62M 13.33M 577M EV / Sales 2017
223x
EV / Sales 2018 29,261x
Free-Float
68.23%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
President - -
Chief Operating Officer - -
Corporate Secretary 60 27/01/2020
Director TitleAgeSince
Director/Board Member 60 16/01/2020
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00% - - 2.09M
+1.09%+5.26%+4.44%+26.03% 51.61B
-1.07%+2.82%+474.18%+601.24% 44.89B
+1.47%+9.79%+40.15%+21.21% 42.77B
+1.44%+7.77%+19.27%+90.94% 42.58B
-0.93%-4.33%+17.87%+51.96% 31.82B
+1.32%+7.30%+36.93%+152.36% 17.33B
-0.60%+1.93% - - 16.63B
+0.03%+3.41%+7.12%+35.49% 14.76B
+1.28%+5.41%+91.01%+46.93% 14.09B
Average +10.40%+13.99%+86.37%+128.27% 27.65B
Weighted average by Cap. +0.49%+4.72%+102.57%+148.52%

Financials

2017 2018
Net sales 16.01K 13.71K 12.83K 11.75K 22.04K 1.53M 22.34K 152K 59.12K 770K 60.12K 58.81K 2.55M 124 106.22 99.39 90.98 170.74 11.86K 172.99 1.17K 457.91 5.96K 465.61 455.48 19.71K
Net income -481K -412K -385K -353K -662K -46.02M -671K -4.55M -1.78M -23.12M -1.81M -1.77M -76.46M -976K -836K -782K -716K -1.34M -93.34M -1.36M -9.24M -3.6M -46.89M -3.66M -3.58M -155M
Net Debt 497K 425K 398K 364K 684K 47.53M 693K 4.7M 1.83M 23.87M 1.87M 1.82M 78.97M 548K 470K 439K 402K 755K 52.46M 765K 5.19M 2.02M 26.35M 2.06M 2.01M 87.17M
Logo Ephraim Resources Limited
Lanka Graphite Ltd is an Australia-based company. The Company is engaged in the business of agricultural biogenetics research and experimentation, licensing and consultancy. The Company focuses on nipah palm breeding, tissue culture, cultivation and plantation, and the conversion of sap from the nipah palm to sugar and ethanol. The Company operates through two segments: Australia and Indonesia.
Employees
-